Conshohocken’s Cencora To Expand US Pharmaceutical Distribution With $1B Investment

Conshohocken's Cencora plans to expand its pharmaceutical distribution network across the United States with a $1B investment through 2030.

Conshohocken-based Cencora is planning to expand its pharmaceutical distribution network across the United States with a $1 billion investment through 2030, writes John George for the Philadelphia Business Journal.

The plans include opening a second national distribution center in Ohio and increasing the company’s presence in both Alabama and California.

“This investment underscores our commitment to and role in building a resilient pharmaceutical supply chain and in ensuring patients across the United States have timely and reliable access to prescribed medications, where and when they need them,” said Cencora CEO Bob Mauch.

Cencora’s new 530,000-square-foot distribution center in Harrison, Ohio, is expected to begin operations by spring 2027. Featuring advanced automation technology such as robotic handling systems, artificial intelligence, and autonomous mobile robots, the facility is designed to enhance both the efficiency and reliability of the company’s supply chain. The company already operates a distribution center in Columbus, Ohio.

Cencora will also increase its West Coast presence with a 430,000-square-foot distribution center in Fontana, California, that is slated to open in fall 2026. At the same time, the company is expanding its Dothan, Alabama, distribution center, one of its three facilities dedicated to specialty medicines.

Read more about Cencora’s plans for expansion in the Philadelphia Business Journal.




Share This Story:

"*" indicates required fields

This field is hidden when viewing the form
MT Sub
This field is hidden when viewing the form
MT Sub Source


Trending Stories